Chung-Yi Wu
Chief Executive Officer CHO Pharma
Seminars
Monday 3rd November 2025
Leveraging Glycosite-Specific Conjugation for Next-Generation ADCs
1:30 pm
- Enhancing ADC therapeutic index through innovative glycan engineering and SAR-driven design
- Harnessing glycosite-specific conjugation to develop bispecific and dual-payloads ADC
- Leveraging glycosite-specific conjugation for CMC advantages
